These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 3000580

  • 1. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
    Sasaki K, Chida K, Hashiba H, Kamata N, Abe E, Suda T, Kuroki T.
    Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
    [Abstract] [Full Text] [Related]

  • 2. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
    Hosoi J, Abe E, Suda T, Colburn NH, Kuroki T.
    Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
    [Abstract] [Full Text] [Related]

  • 3. Similarity and dissimilarity between phorbol ester tumor promoters and 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3.
    Kuroki T, Suda T.
    Princess Takamatsu Symp; 1983 Nov; 14():89-99. PubMed ID: 6394594
    [Abstract] [Full Text] [Related]

  • 4. [Regulation of tumor promotion by 1 alpha, 25-dihydroxyvitamin D3, an active form of vitamin D3].
    Kuroki T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):766-72. PubMed ID: 3754414
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by 1 alpha, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B.
    Chida K, Hashiba H, Suda T, Kuroki T.
    Cancer Res; 1984 Apr; 44(4):1387-91. PubMed ID: 6423272
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumor promotion in mouse skin by 1 alpha,25-dihydroxyvitamin D3.
    Chida K, Hashiba H, Fukushima M, Suda T, Kuroki T.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5426-30. PubMed ID: 3840412
    [Abstract] [Full Text] [Related]

  • 7. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
    Hosoi J, Abe E, Suda T, Kuroki T.
    Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
    [Abstract] [Full Text] [Related]

  • 8. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
    Jeng AY, Lichti U, Strickland JE, Blumberg PM.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
    [Abstract] [Full Text] [Related]

  • 9. Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters.
    Chida K, Hashiba H, Sasaki K, Kuroki T.
    Cancer Res; 1986 Mar; 46(3):1055-62. PubMed ID: 3080229
    [Abstract] [Full Text] [Related]

  • 10. 1 alpha,25-Dihydroxyvitamin D3 markedly enhances chemically-induced transformation in BALB 3T3 cells.
    Kuroki T, Sasaki K, Chida K, Abe E, Suda T.
    Gan; 1983 Oct; 74(5):611-4. PubMed ID: 6315520
    [Abstract] [Full Text] [Related]

  • 11. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M, Eisman JA, Sutherland RL.
    Cancer Res; 1988 May 15; 48(10):2734-9. PubMed ID: 2834048
    [Abstract] [Full Text] [Related]

  • 12. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
    Sylvia VL, Schwartz Z, Schuman L, Morgan RT, Mackey S, Gomez R, Boyan BD.
    J Cell Physiol; 1993 Nov 15; 157(2):271-8. PubMed ID: 8227160
    [Abstract] [Full Text] [Related]

  • 13. 1,25-Dihydroxyvitamin D3 and macrophage colony-stimulating factor-1 synergistically phosphorylate talin.
    Meenakshi T, Ross FP, Martin J, Teitelbaum SL.
    J Cell Biochem; 1993 Oct 15; 53(2):145-55. PubMed ID: 8227187
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
    Kong J, Li YC.
    Am J Physiol Endocrinol Metab; 2006 May 15; 290(5):E916-24. PubMed ID: 16368784
    [Abstract] [Full Text] [Related]

  • 15. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
    Hashiba H, Fukushima M, Chida K, Kuroki T.
    Cancer Res; 1987 Oct 01; 47(19):5031-5. PubMed ID: 3621189
    [Abstract] [Full Text] [Related]

  • 16. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
    Ittel TH, Ross FP, Norman AW.
    J Bone Miner Res; 1986 Feb 01; 1(1):23-31. PubMed ID: 3509739
    [Abstract] [Full Text] [Related]

  • 17. Synergism and antagonism in the effects of 1 alpha,25-dihydroxyvitamin D3, retinoic acid, dexamethasone, and a tumor-promoting phorbol ester on the functional capability of P388D1 cells: phagocytosis and transglutaminase activity.
    Goldman R.
    Cancer Res; 1985 Jul 01; 45(7):3118-24. PubMed ID: 2860969
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):181-7. PubMed ID: 9224728
    [Abstract] [Full Text] [Related]

  • 19. Promoter-induced cellular responses closely correlated with the enhancement of cell transformation.
    Kakunaga T, Hirakawa T, Shimomura K, Sugimura T.
    Princess Takamatsu Symp; 1983 Jul 15; 14():303-13. PubMed ID: 6097582
    [Abstract] [Full Text] [Related]

  • 20. Effects of retinoic acid on the activation and fusion of mouse alveolar macrophages induced by 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C, Segawa A, Nagasawa H, Abe E, Suda T.
    J Bone Miner Res; 1986 Aug 15; 1(4):359-68. PubMed ID: 3503549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.